v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 7,176,615 $ 63,741
Prepaid expenses 117,071 94,070
Total current assets 7,293,686 157,811
Other assets:    
Licenses 2,251,134 2,251,134
Patents 48,420 48,420
Total other assets 2,299,554 2,299,554
Total assets 9,593,240 2,457,365
Current liabilities:    
Accounts payable 44,607 63,686
Accrued expenses 32,157 912,095
Notes payable 240,753
Total current liabilities 76,764 1,247,534
Warrant liability 53,000 24,486
Total liabilities 129,764 1,272,020
Commitments and contingencies (Note 10)
STOCKHOLDERS’ EQUITY    
Preferred stock, par value $0.0001, 100,000,000 shares authorized; 0 issued and outstanding as of December 31, 2025 and December 31, 2024
Common stock, par value $0.0001, 1,000,000,000 shares authorized; 72,536,722 and 27,080,915 shares issued and outstanding as of December 31, 2025 and 2024, respectively 7,254 2,708
Common stock to be issued 516,000
Additional paid-in capital 30,054,695 11,745,436
Accumulated deficit (21,114,473) (10,562,799)
Total stockholders’ equity 9,463,476 1,185,345
Total liabilities and stockholders’ equity 9,593,240 2,457,365
Related Party    
Current liabilities:    
Notes payable to related parties $ 31,000